Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination

Melanoma patients with regional metastatic disease are at high risk for recurrence and metastatic disease, despite radical lymph node dissection (RLND). We investigated the immunologic response and clinical outcome to adjuvant dendritic cell (DC) vaccination in melanoma patients with regional metast...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Bol, Kalijn F, Aarntzen, Erik H J G, Hout, Florentien E M in 't, Schreibelt, Gerty, Creemers, Jeroen H A, Lesterhuis, W Joost, Gerritsen, Winald R, Grunhagen, Dirk J, Verhoef, Cornelis, Punt, Cornelis J A, Bonenkamp, Johannes J, de Wilt, Johannes H W, Figdor, Carl G, de Vries, I Jolanda M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4760342/
https://ncbi.nlm.nih.gov/pubmed/26942068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1057673
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller